ARK Genomic Revolution ETF (ARKG)
ARK Genomic Revolution ETF operates in the Asset Management industry of the Financial Services sector, headquartered in St. Petersburg, FL, US. The stock last traded at $51.63, down 0.03% on the session, giving a market capitalisation of $1.80B. Its beta of 2.38 implies it has historically moved more than the broad market.
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.
ARK Genomic Revolution ETF is most often compared with the following Financial Services names: